Cholestatic and Autoimmune Diseases SIG: Advancing AIH Understanding and Care

5 (2 votes)

Recorded On: 11/09/2018

This program presents an update on the current state of knowledge about autoimmune hepatitis and identify the gaps in knowledge related to the immunologic, environmental, and genetic factors underlying AIH. The program will also review clinical management, identify unmet needs, and discuss barriers along the path toward development of new therapies for AIH.

Christopher L. Bowlus (Moderator)

Dr. Christopher Bowlus obtained his medical degree at St. Louis University and completed his postgraduate training at University of California Davis and Yale University. Dr. Bowlus is Professor of Medicine and Chief of the Division of Gastroenterology and Hepatology at UC Davis. Dr. Bowlus conducts clinical and translational research in autoimmune liver diseases including primary biliary cholangitis and primary sclerosing cholangitis.

Luca Fabris (Moderator)

David Assis

Craig Lammert

Nanda Kerkar

Dermot Gleeson

Christoph Schramm

Key:

Complete
Failed
Available
Locked
Introduction
Open to view video.
Open to view video.
Immunopathogenesis of AIH
Open to view video.
Open to view video.
Genetic and Environmental Risk Factor for AIH
Open to view video.
Open to view video.
AIH in Special Populations (Children and Minorities)
Open to view video.
Open to view video.
Panel Discussion/Q&A
Open to view video.
Open to view video.
Long Term Outcomes of AIH
Open to view video.
Open to view video.
AIH Beyond Steroids: Effective Trial Design and Attention to Quality of Life
Open to view video.
Open to view video.
Panel Discussion/Q&A
Open to view video.
Open to view video.
Final Evaluation
Final Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.